Homecare Service for Administration of Lanreotide Autogel Injections: Assessment of Patients’ Experience
Introduction: In the past, all Neuroendocrine Neoplasm (NEN) patients (pts) on long-acting somatostatin analogues (SA), had to attend local hospitals/clinics to have them administered by nurses/doctors. Recently, a “homecare service” was developed, allowing pts to have their injections delivered to their home and injections were either administered by themselves, their partner or a Specialist Nurse (SN).
Aim(s): To assess the pts’ experience of the “homecare service” for Lanreotide Autogel (LA) injections
Materials and methods: An anonymized questionnaire was sent to 65 of NEN pts using the “homecare service”. Responses were received from 34 patients.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Gertner J
To read the full abstract, please log into your ENETS Member account.